The University of Göttingen, officially the Georg August University of Göttingen, is a public research university in the city of Göttingen, Germany.

During the past decade, Georg-August-Universität Göttingen conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Georg-August-Universität Göttingen" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Coloplast A/S" with 2 trials sponsored, "Corvia Medical" with 2 trials sponsored and "Pari Pharma GmbH" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Georg-August-Universität Göttingen" #1 collaborator was "German Federal Ministry of Education and Research" with 2 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "B. Braun Melsungen AG" with 1 trials as a collaborator, "Bausch Health Americas, Inc." with 1 trials as a collaborator and "City of Hope Medical Center" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Georg-August-Universität Göttingen" are "Heart Failure" (3 trials), "Melanoma" (3 trials), "Melanoma (Skin)" (3 trials), "ADHD" (2 trials) and "Leg Ulcers" (2 trials). Many other conditions were trialed in "Georg-August-Universität Göttingen" in a lesser frequency.

Most popular intervention types in "Georg-August-Universität Göttingen" are "Drug" (23 trials), "Biological" (6 trials), "Device" (6 trials), "Procedure" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Biatain Ibu" (2 trials), "Budesonide" (2 trials), "Carboplatin" (2 trials) and "Erlotinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Georg-August-Universität Göttingen" are 36 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Georg-August-Universität Göttingen". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Georg-August-Universität Göttingen, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Georg-August-Universität Göttingen, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".

Georg-August-Universität Göttingen has several departments that took part in Clinical trials: "Department of Neurology, University of Goettingen" - 2 trials